Mary Agnes Wilderotter - 05 Jun 2025 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role: Director
Signature: /s/ Bernard J. Cassidy, Attorney-in-Fact for Mary Agnes Wilderotter
Issuer symbol: SANA
Transactions as of: 05 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 09 Jun 2025, 16:38:58 UTC
Previous filing: 30 May 2025
Next filing: 13 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Wilderotter Mary Agnes	Director	C/O SANA BIOTECHNOLOGY, INC., 188 EAST BLAINE STREET, SUITE 400, SEATTLE	/s/ Bernard J. Cassidy, Attorney-in-Fact for Mary Agnes Wilderotter	09 Jun 2025	0001180610

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SANA	Stock Option (Right to Buy)	Award	$0	+80,000		$0.000000	80,000	05 Jun 2025	Common Stock	80,000	$2.55	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 5, 2026 and (ii) immediately prior to the 2026 annual meeting of stockholders of Sana Biotechnology, Inc. ("Sana"), provided that the reporting person provides continuous service to Sana through such date.